No Data
No Data
Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025
Express News | Appili Therapeutics Inc - Four New Funding Proposals, Totalling US$117.5 Mln, Submitted for Review
Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update
Express News | Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic Adi Platform, Advancing Toward First-in-Human Clinical Trials
Appili Therapeutics Announces Receipt of Final Court Order for Arrangement With Aditxt, Inc.
Appili Therapeutics Inc: INTERIM MDA EN